5-Oxo-L-prolyl-L-alpha-aspartyl-L-prolyl-L-phenylalanyl-L-leucyl-N~5~-(diaminomethylene)-L-ornithyl-L-phenylalaninamide(CAS: 98495-35-3)

This compound is subject to various regulatory guidelines including GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for classification and labelling, REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) for European Union member states, and FDA (Food and Drug Administration) and EPA (Environmental Protection Agency) requirements in the United States. Specific regulations will vary based on the intended use and application.

Alternatives to this compound in synthesis include other cyclic peptidomimetics, such as peptoids or small molecule mimetics. These alternatives can serve as effective substitutes depending on the specific application and synthesis requirements.

The market for this compound is primarily driven by its potential applications in pharmaceuticals and medicinal chemistry. Research trends indicate increasing interest in this compound for its biological activity, particularly in targeted drug delivery and immunology research. Additionally, there is growing exploration in its use as a model compound in peptide chemistry.

Waste containing this compound should be collected in appropriate containers and disposed of according to local regulations. For professional disposal, incineration is an effective method. Environmental protection measures include ensuring the waste is neutralized and treated to minimize environmental impact. Safe handling and storage practices must be followed at all times to prevent contamination and ensure worker safety.